Generation and characterization of an ascitogenic mesothelin-expressing tumor model
Open Access
- 29 June 2007
- Vol. 110 (2), 420-431
- https://doi.org/10.1002/cncr.22781
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Diagnosis and Management of Epithelial Ovarian CancerObstetrics & Gynecology, 2006
- Management of Platinum-Sensitive Recurrent Ovarian CancerSeminars in Oncology, 2006
- Systemic Therapy for Ovarian Cancer: Current Status and New TreatmentsSeminars in Oncology, 2006
- Diffuse Mesothelin Expression Correlates with Prolonged Patient Survival in Ovarian Serous CarcinomaClinical Cancer Research, 2006
- MesothelinClinical Cancer Research, 2004
- A Genetically Defined Model for Human Ovarian CancerCancer Research, 2004
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Effect of Local Anti-VEGF Antibody Treatment on Tumor Microvessel PermeabilityMicrovascular Research, 1999
- Role of Vascular Endothelial Growth Factor in Ovarian CancerThe American Journal of Pathology, 1998
- Establishment of a murine model of malignant mesotheliomaInternational Journal of Cancer, 1992